Effect of Dash Diet and Acupuncture on Hypertention in Postmenopausal Women

• Sponsor: Cairo University (Other)
• Overall Status: Completed
• CT.gov ID: NCT06015919
• Collaborator: faculty of physical therapy (Other)
• Enrollment: 45
• Location: 1
• Arm: 1
• Actual Duration (Months): 8.5
• Patients Per Site Per Month: 5.3

Study Details

Study Description

Brief Summary

A study of effect of dash diet and acupuncture on hypertension in postmenopausal women

Condition or Disease	Intervention/Treatment	Phase
Postmenopausal Disorder	Behavioral: dash diet; Device: Acupuncture	N/A

Detailed Description

45 of post menopausal women divided into three groups A,B,C

• Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs.

• Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs.

• Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.

Study Design

• Study Type: Interventional
• Actual Enrollment: 45 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Intervention Model Description: dash diet and acupuncture on post menopausal hypertentiondash diet and acupuncture on post menopausal hypertention
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: Effect of Dash Diet and Acupuncture on Hypertention in Postmenopausal Women
• Actual Study Start Date: Dec 5, 2022
• Actual Primary Completion Date: Apr 25, 2023
• Actual Study Completion Date: Aug 20, 2023

Arms and Interventions

Arm

Intervention/Treatment

Experimental: effect of dash diet and acupuncture on hypertention in post menopausal women Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs. Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs. Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.

Behavioral: dash diet; Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs. Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs. Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.; Device: Acupuncture; acupuncture

Outcome Measures

Primary Outcome Measures

1. blood pressure [3 months]

   it will be measured by sphygmomanometer pre and post treatment

Secondary Outcome Measures

1. sodium and potassium levels [3 months]

   it will be measured by blood analysis pre and post treatment

Other Outcome Measures

1. assessment of quality of life [3 months]

   it will be measured by sf 36 questionnaire pre and post treatment

Eligibility Criteria

Criteria

• Ages Eligible for Study: 50 Years to 60 Years
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Their body mass index will be ranged from 25 -29.9 kg/m2

• All patients will be medically stable when attending the study.

• The DASH eating plan of 1800 kcal per day will be used in the study.

Exclusion Criteria:

• Auditory and visual problems.

• Chronic renal failure.

• Myocardial infarction or arrythmias with heart failure.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Alaa Nabil Elsayed Mohamed	Abu hammad	Elsharqia	Egypt	44661

Sponsors and Collaborators

• Cairo University
• faculty of physical therapy

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Alaa Nabil Elsayed Mohamed, principal investigator, Cairo University
• ClinicalTrials.gov Identifier: NCT06015919
• Other Study ID Numbers: P.T.REC/012/003872
• First Posted: Aug 29, 2023
• Last Update Posted: Aug 29, 2023
• Last Verified: Aug 1, 2023

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of Aug 29, 2023